GORE® EXCLUDER® AAA ENDOPROSTHESIS
Report
- Report Number
- 2017233-2014-00177
- Event Type
- Injury
- Date Received
- April 4, 2014
- Date of Event
- March 4, 2014
- Report Date
- April 3, 2014
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IL, US
- Reporter Occupation
- PHYSICIAN
Narratives
EXCLUDER DEVICES INCLUDED IN THIS REPORT: RMT281214/9343327, PXC121000/9212400. A REVIEW OF THE MANUFACTURING AND STERILIZATION PAPERWORK FOR THE DEVICES VERIFIED THAT THE LOTS MET ALL PRE-RELEASE SPECIFICATIONS. PER THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE (IFU), ADVERSE EVENTS THAT MAY OCCUR AND / OR REQUIRE INTERVENTION INCLUDE, BUT ARE NOT LIMITED TO ENDOPROSTHESIS INFECTION AND SURGICAL CONVERSION.
CONCOMITANT MEDICAL PRODUCTS: PATIENT MEDICATIONS INCLUDE DAPTOMYCIN, ASPIRIN, LINEZOLID, CARVEDILOL, SERTRALINE, NORCO, BUMEX, CEFAZOLIN, DOCUSATE, AND LOVENOX.
ON (B)(6) 2012, THE PATIENT WAS IMPLANTED WITH TWO GORE EXCLUDER AAA ENDOPROSTHESES (RMT281214/9343327 AND PXC121000/9212400) TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON VARIOUS UNKNOWN DATES, MULTIPLE DIAGNOSTIC EXAMINATIONS (COMPUTED TOMOGRAPHY, GASTRO-INTESTINAL SCOPES, MAGNETIC RESONANCE) REVEALED RECURRENT SEPSIS OF UNKNOWN ORIGIN, AND AN INFECTED STENT GRAFT IN THE INFRARENAL AORTA. ON (B)(6) 2014, THE PATIENT UNDERWENT A PROCEDURE WHEREBY THE EXCLUDER GRAFT SYSTEM WAS EXPLANTED, AND THE THORACIC AND INFRARENAL AORTA WAS SURGICALLY REPAIRED. THE PATIENT TOLERATED THE PROCEDURE. THE EXPLANTED GRAFTS WERE DISCARDED AT THE FACILITY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 204453 | GORE® EXCLUDER® AAA ENDOPROSTHESIS | SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES | 9343327 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 70 YR | Hospitalization| R |